Literature DB >> 4512589

Influence of lysolecithin on platelet aggregation initiated by 5-hydroxytryptamine.

E M Besterman, M P Gillett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4512589     DOI： 10.1038/newbio241223a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  11 in total

1.  Proceedings Correlation between ultrastructure and histochemistry of mammalian intrafusal muscle fibres.

Authors:  R W Banks; D Barker; D W Harker; M J Stacey
Journal:  J Physiol       Date:  1975-11       Impact factor: 5.182

2.  Proceedings: Electrophysiological studies of the brain of Octopus vulgaris.

Authors:  R O Stephen
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

3.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

4.  Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.

Authors:  D J Boullin; H F Woods; R P Grimes; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

5.  The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients.

Authors:  M W Orr; J M Knox; R Allen; M G Gelder; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

6.  Lysophosphatidylcholine-induced gastric injury and ulceration in the guinea pig.

Authors:  J Maksem; N Jacobson; D H Neiderhiser
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

7.  Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

8.  The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.

Authors:  J De Cree; J Leempoels; B Demoen; V Roels; H Verhaegen
Journal:  Agents Actions       Date:  1985-07

9.  Characterization of 5-hydroxytryptamine binding sites in the plasma membrane of pig blood platelets.

Authors:  D Hoffmann; W Wesemann
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Effect of lysolecithin on blood vessel reactivity and of some ethers and esters of glycerophosphocholine and phosphocholine, respectively, on aggregation of rat platelets.

Authors:  H Bekemeier; H A Bakathir; A J Giessler; R Hirschelmann; P Nuhn
Journal:  Agents Actions       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.